303 results match your criteria: "Centre d'evaluation et de traitement de la douleur[Affiliation]"
Med Mal Infect
March 2019
FHU INOVPAIN, centre d'évaluation et de traitement de la douleur, CHU de Timone, pôle de neurosciences cliniques, 13005 Marseille, France.
Lyme disease is caused by bacteria of the B. burgdorferi sensu lato complex, and can give polymorphic clinical manifestations that can affect several organs such as the skin, the central nervous system, or the joints. In recent years, patients' associations and physicians have been supporting the hypothesis that this infection would manifest as chronic generalized musculoskeletal pain symptoms, named "chronic Lyme disease".
View Article and Find Full Text PDFWellcome Open Res
February 2019
Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, OX3 9DU, UK.
Neuropathic pain is an increasingly prevalent condition and has a major impact on health and quality of life. However, the risk factors for the development and maintenance of neuropathic pain are poorly understood. Clinical, genetic and psychosocial factors all contribute to chronic pain, but their interactions have not been studied in large cohorts.
View Article and Find Full Text PDFNeurophysiol Clin
June 2019
Laboratoire d'automatique, de mécanique et d'informatique industrielles et humaines (LAMIH), UMR CNRS 8201, université de Valenciennes et du Hainaut-Cambrésis (UVHC), 59313 Valenciennes, France; Posture Lab, 75012 Paris, France.
Postural control requires constant and subconscious postural sway to manage balance and achieve postural stability. These movements of regulation are based in particular on cutaneous plantar information. The foot constitutes a functional whole that participates in the mechanisms of postural control and regulation.
View Article and Find Full Text PDFFoot Ankle Int
April 2019
1 Service d'anesthésie, Hôpital Raymond Poincaré, Garches, Assistance Publique Hôpitaux de Paris, France.
Background:: The pain trajectory after ankle surgeries for osteoarthritis is relevant to describe. The purpose of this prospective study was to describe pain after ankle surgery and explore the link between perioperative factors and the development of postoperative pain.
Methods:: Duration, severity, type of preoperative pain, psychological distress, opioid consumption, and type of surgery were evaluated in 49 patients who were followed for 18 months.
Lancet Neurol
January 2019
INSERM U 987, Centre d'Evaluation et de Traitement de la Douleur, CHU Ambroise Paré, Assistance Publique-Hôpitaux de Paris, 92100 Boulogne-Billancourt, France; Université Versailles-Saint-Quentin, Versailles, France.
Curr Med Res Opin
March 2019
c Centre d'Evaluation et de Traitement de la Douleur, Hôpital Cochin, Assistance Publique des Hôpitaux de Paris (AP-HP), Université Paris Descartes, Paris , France.
Objective: To describe the characteristics of patients treated with the capsaicin 8% patch, prescribing conditions, long-term effects of repeat treatment on pain intensity and perception, quality of life, and impact on concomitant medication.
Methods: A national, longitudinal, prospective, non-interventional, post-marketing open study was conducted in 50 French pain centers. Adult volunteer non-diabetic patients with peripheral neuropathic pain receiving capsaicin 8% patch treatment were consecutively enrolled.
Rev Neurol (Paris)
June 2019
Inserm U1028, CNRS, UMR5292, central integration of pain (NeuroPain) Lab - Lyon neuroscience research center, université Claude Bernard, 69677 Bron, France; Department of Clinical Neurophysiology, Neurological Institute, Faculty of Medicine, Graduate School of Medical Science, Kyushu University, Fukuoka, 812-8582, Japan.
Electrophysiological techniques demonstrate abnormalities in somatosensory transmission, hence providing objective evidence of 'somatosensory lesion or disease' which is crucial to the diagnosis of neuropathic pain (NP). Since most instances of NP result from damage to thermo-nociceptive pathways (thin fibres and spino-thalamo-cortical systems), specific activation of these is critical to ensure diagnostic accuracy. This is currently achieved using laser pulses or contact heat stimuli, and in a near future probably also with contact cold and intra-epidermal low-intensity currents.
View Article and Find Full Text PDFRev Neurol (Paris)
June 2019
Inserm U987, "Pathophysiology and Clinical Pharmacology of Pain", centre d'évaluation et de traitement de la douleur, hôpital Ambroise Paré, 9, avenue Charles de Gaulle, 92100 Boulogne-Billancourt, France. Electronic address:
Neuropathic pain has been a very active and productive clinical research field over the last 15 years. Studies have concerned multiple aspects of these complex chronic pain syndromes including their very definition, the elaboration of new diagnostic algorithms, the development of specific tools for their screening and measurement and their epidemiology. In this review, we summarize these recent evolutions that have impacted the way these pain syndromes are conceptualized and managed both in daily practice and in the clinical research setting.
View Article and Find Full Text PDFBrain Stimul
March 2019
Central Integration of Pain (NeuroPain) Lab-Lyon Neuroscience Research Center, INSERM U1028, CNRS, UMR5292, Université Claude Bernard, Bron, F-69677, France; Centre D'évaluation et de Traitement de la Douleur, Hôpital Neurologique, Lyon, F-69000, France.
Rev Neurol (Paris)
June 2019
Inserm U-987, centre d'évaluation et de traitement de la douleur, CHU Ambroise-Paré, AP-HP, 92100 Boulogne-Billancourt, France; Université Versailles Saint-Quentin, 78035 Versailles, France. Electronic address:
We provide an up-to-date review of the pharmacological treatment of neuropathic pain with emphasis on the latest evidence-based recommendations for its pharmacological treatment. Drugs proposed as first line include tricyclic antidepressants (particularly amitriptyline), serotonin-norepinephrine reuptake inhibitors (particularly duloxetine), pregabalin and gabapentin. Second line treatments include lidocaine plasters and capsaicin high concentration patches for peripheral neuropathic pain only, and tramadol.
View Article and Find Full Text PDFEur J Neurosci
November 2018
Central Integration of Pain (NeuroPain) Lab-Lyon Neuroscience Research Center, INSERM U1028, CNRS, UMR5292, Université Claude Bernard, Bron, France.
Intra-epidermal electrical stimulation (IEES) has been shown to activate selectively Aδ fibers subserving spinothalamic-mediated sensations. Owing to electrically induced highly synchronous afferent volleys, IEES induces Aδ-mediated evoked potentials at nonpainful intensities, contrasting with thermo-nociceptive laser pulses which entail painful pricking sensations. Here, we recorded intracortical responses from sensory and limbic-cognitive regions of human subjects in response to IEE and laser stimuli, in order to test the hypothesis that IEES could dissociate the sensory from nonsensory networks of nociceptive processing.
View Article and Find Full Text PDFNeurophysiol Clin
December 2018
UMR CNRS 8201, laboratoire d'automatique de mécanique et d'informatique industrielles et Humaines (LAMIH), université de Valenciennes et du Hainaut-Cambrésis (UVHC), 59313 Valenciennes, France.
The purpose of the study was to evaluate the effect of an additional thickness placed under the toes (TUT) on the CoP measures and to determine the optimum thickness required to maximize the postural control performance. Four conditions were compared: TUT 0 (control), 0.8, 3, and 6mm and four variables were computed from the CoP displacements.
View Article and Find Full Text PDFSci Rep
September 2018
Central Integration of Pain (NeuroPain) Lab - Lyon Neuroscience Research Center, INSERM U1028; CNRS. UMR5292, Université Claude Bernard, Bron, F-69677, France.
Two parallel di-synaptic routes convey nociceptive input to the telencephalon: the spino-thalamic system projecting principally to the posterior insula, and the spino-parabrachial pathway reaching the amygdalar nucleus. Interplay between the two systems underlies the sensory and emotional aspects of pain, and was explored here in humans with simultaneous recordings from the amygdala, posterior and anterior insulae. Onsets of thermo-nociceptive responses were virtually identical in the posterior insula and the amygdalar complex, but no significant functional connectivity was detected between them using coherence analysis.
View Article and Find Full Text PDFEur J Neurosci
September 2018
Centre National de la Recherche Scientifique, Institut des Neurosciences Cellulaires et Intégratives, Université de Strasbourg, Strasbourg, France.
Peripheral delta opioid (DOP) receptors are essential for the antiallodynic effect of the tricyclic antidepressant nortriptyline. However, the population of DOP-expressing cells affected in neuropathic conditions or underlying the antiallodynic activity of antidepressants remains unknown. Using a mouse line in which DOP receptors were selectively ablated in cells expressing Nav1.
View Article and Find Full Text PDFPain
November 2018
INSERM U-987, Centre d'Evaluation et de Traitement de la Douleur, Hôpital Ambroise Paré, Assistance Publique Hôpitaux de Paris, Boulogne-Billancourt, France.
Multiple recent pharmacological clinical trials in neuropathic pain have failed to show beneficial effect of drugs with previously demonstrated efficacy, and estimates of drug efficacy seems to have decreased with accumulation of newer trials. However, this has not been systematically assessed. Here, we analyze time-dependent changes in estimated treatment effect size in pharmacological trials together with factors that may contribute to decreases in estimated effect size.
View Article and Find Full Text PDFNeurochirurgie
September 2018
Département de neurochirurgie, 69000 Lyon, France.
Rev Med Interne
August 2018
Service d'anesthésie, hôpital Raymond-Poincaré, Assistance publique-Hôpitaux de Paris, 92380 Garches, France; Inserm, U-987, hôpital Ambroise-Paré, Centre d'évaluation et de traitement de la douleur, 92100 Boulogne-Billancourt, France; Université Versailles Saint-Quentin, 78035 Versailles, France. Electronic address:
Rev Med Interne
June 2018
Service d'addictologie, CS10217, université Grenoble-Alpes, CHU de Grenoble-Alpes, 38043 Grenoble cedex, France.
Eur J Med Chem
March 2018
CNRS, Université de Strasbourg, UMR7200 Laboratoire d' Innovation Thérapeutique, 67401 Illkirch, France; Labex MEDALIS, 67000 Strasbourg, France. Electronic address:
4-phenylpyridin-2-yl-guanidine (5b): a new inhibitor of the overproduction of pro-inflammatory cytokines (TNFα and Il1β) was identified from a high-throughput screening of a chemical library on human peripheral blood mononuclear cells (PBMCs) after LPS stimulation. Derivatives, homologues and rigid mimetics of 5b were designed and synthesized, and their cytotoxicity and ability to inhibit TNFα overproduction were evaluated. Among them, compound 5b and its mimetic 12 (2-aminodihydroquinazoline) showed similar inhibitory activities, and were evaluated in vivo in models of lung inflammation and neuropathic pain in mice.
View Article and Find Full Text PDFHeadache
April 2018
Centre d'évaluation et de traitement de la douleur, Hopital La Timone, France.
Objective: To investigate the headache characteristics and clinical features of elderly migraine patients at a tertiary headache center.
Methods: We retrospectively reviewed 239 records of migraine patients, over the age of 64 at the first visit, who had migraine as defined by the International Classification of Headache Disorders 3rd edition (beta version) from 2006 to 2015 based on the Marseille registry at Timone Hospital.
Results: 13.
Mol Pain
October 2018
2 Institut des Neurosciences Cellulaires et Intégratives, Centre National de la Recherche Scientifique, Strasbourg, France.
Geriatr Psychol Neuropsychiatr Vieil
December 2017
Laboratoire Mundipharma, Paris, France.
Cognitive impairment is commonly associated with the pain experience. This deterioration regarding several cognitive domains such as attention, speed of information processing, memory, learning and executive functions, represents a major obstacle to daily activities and mobility especially in the elderly for whom a decrease in mobility is a significant risk factor for death and disability. Regarding the demographic rising in the elderly population expected by 2050 (the proportion of persons aged 60 and above is expected to double according to ONU estimate) and the high prevalence of pain in this age reaching 80% in nursing homes, clinicians should be better aware of the links between pain and cognition in this population's segment so that they offer each patient an appropriate treatment.
View Article and Find Full Text PDFBr J Anaesth
October 2017
Academic Unit of Palliative Care, Leeds Institute of Health Sciences, University of Leeds, UK.
Background: The objectives of this study were to evaluate the methodological quality of rigorous neuropathic pain assessment tools in applicable clinical studies, and determine the performance of screening tools for identifying neuropathic pain in patients with cancer.
Methods: Systematic literature search identified studies reporting use of Leeds Assessment of Neuropathic Symptoms and Signs (LANSS), Douleur Neuropathique en 4 (DN4) or painDETECT (PDQ) in cancer patients with a clinical diagnosis of neuropathic or not neuropathic pain. Individual patient data were requested to examine descriptor item profiles.
Eur J Pain
February 2018
Mech-Sense, Department of Gastroenterology and Hepatology, Clinical Institute, Aalborg University Hospital, Aalborg, Denmark.
Unlabelled: Different neuroplastic processes can occur along the nociceptive pathways and may be important in the transition from acute to chronic pain and for diagnosis and development of optimal management strategies. The neuroplastic processes may result in gain (sensitisation) or loss (desensitisation) of function in relation to the incoming nociceptive signals. Such processes play important roles in chronic pain, and although the clinical manifestations differ across condition processes, they share some common mechanistic features.
View Article and Find Full Text PDFTrials
November 2017
Centre de Pharmacologie Clinique, Bâtiment 3C, CIC Inserm 1405, CHU Clermont-Ferrand, BP 69, F-63003, Clermont-Ferrand, Cedex 1, France.
Background: Neuropathic pain is difficult to treat, and the efficacy of recommended drugs remains limited. N-methyl-D-aspartate receptors are implicated, and antagonists are a pharmacological option. Ketamine is widely used in French pain clinics, but without consensus or recommendations.
View Article and Find Full Text PDF